K850-0217 Screening compound: 2-{6-[4-(4-fluorophenyl)piperazine-1-carbonyl]-5-methyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl}-N-(2-methoxyphenyl)acetamide

K850-0217 Screening compound: 2-{6-[4-(4-fluorophenyl)piperazine-1-carbonyl]-5-methyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl}-N-(2-methoxyphenyl)acetamide
K850-0217 Screening compound: 2-{6-[4-(4-fluorophenyl)piperazine-1-carbonyl]-5-methyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl}-N-(2-methoxyphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K850-0217
2-{6-[4-(4-fluorophenyl)piperazine-1-carbonyl]-5-methyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl}-N-(2-methoxyphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K850-0217

Molecular Formula

C27H26FN5O4S (C27 H26 FN5 O4 S)

Compound Name

2-{6-[4-(4-fluorophenyl)piperazine-1-carbonyl]-5-methyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl}-N-(2-methoxyphenyl)acetamide

IUPAC name

2-{6-[4-(4-fluorophenyl)piperazine-1-carbonyl]-5-methyl-4-oxo-3H4H-thieno[23-d]pyrimidin-3-yl}-N-(2-methoxyphenyl)acetamide

SMILES

Cc1c(C(N(CC2)CCN2c(cc2)ccc2F)=O)sc(N=CN2CC(Nc(cccc3)c3OC)=O)c1C2=O

InChI

InChI=1S/C27H26FN5O4S/c1-17-23-25(29-16-33(26(23)35)15-22(34)30-20-5-3-4-6-21(20)37-2)38-24(17)27(36)32-13-11-31(12-14-32)19-9-7-18(28)8-10-19/h3-10,16H,11-15H2,1-2H3,(H,30,34)

InChI Key

GDUQWGQHIJSRIW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15110800

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

535.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.126

Distribution Coefficient, logD

3.126

Water Solubility, LogSw

-3.36

Polar Surface Area

76.232

Acid Dissociation Constant (pKa)

11.49

Base Dissociation Constant (pKb)

5.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.90

K850-0217 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with K850-0217 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K850-0217?
Check Price and Availability of K850-0217, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K850-0217 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K850-0217
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K850-0217
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K850-0217 available by request